CXCL12 and hepatocellular carcinoma: Our team discovered that cancer-originated DNA can activate the CXCL12-CXCR4 and CCL21-CCR7 axes in HCC cells, while sinoline treatment reduced the expressions of CXCL12, CXCR4, CCL21, and CCR7 in HCC cells.